Leo Pharma

Type: Company
Name: Leo Pharma
Web Address: http://www.leo.se
First reported Jul 25 2014 - Updated Jul 25 2014 - 2 reports

Common Treatment for Pregnant Women May Be Ineffective

(dailyRx News) A common treatment for pregnant women prone to blood clots is a daily injection of blood thinner into the stomach. It's intended to prevent pregnancy complications, but recent research suggests this treatment may not work.New research from ... [Published Daily Rx - Jul 25 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Virobay banks $8M to accelerate its treatments for pain, autoimmunity

Menlo Park, CA, biotech Virobay tacked another $8 million onto its Series B financing, collecting cash to advance its treatments for neuropathic pain, autoimmune disease and fibrosis.The latest tranche brings Virobay's B round to $18 million in total, ... [Published FierceBiotech - Jul 17 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Laser discovery treats skin cancer without leaving scars

Danish researchers have helped to develop a new technique that is easy on the patientsMore Danes are being diagnosed with skin cancer (Photo: Colourbox)11:49Doctors at Bispebjerg Hospital in Copenhagen and Harvard Medical School in Boston have developed ... [Published Copenhagen Post - Jul 17 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 2 reports

LEO Pharma, KLOX Tech to develop BioPhotonic acne treatment platform

LEO Pharma and KLOX Technologies announced they have entered into a worldwide license and joint venture agreement to further the development and marketing of KLOX’s BioPhotonic dermatology technology platform.The CE-approved acne treatment uses a non-abrasive, ... [Published Orthopedics Today - Jul 16 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 3 reports

Leo Pharma and Klox Technologies agree dermatology deal

:59 in Pharmaceutical Company Product News Leo Pharma has announced a new alliance with Klox Technologies that expand both companies' capabilities in the field of dermatology. The worldwide licence and joint venture agreement - which excludes Klox's native ... [Published Zenopa - Jul 16 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

New Market Research Report: LEO Pharma A/S - Product Pipeline Review - 2014

at 09:15 AM EDT Boston, MA -- (SBWIRE) -- 07/15/2014 -- Global Markets Direct's, 'LEO Pharma A/S - Product Pipeline Review - 2014', provides an overview of the LEO Pharma A/S's pharmaceutical research and development focus. ... [Published Fat Pitch Financials - Jul 15 2014]
Entities: Leo Pharma, Pipeline, Review
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

LEO Pharma receives marketing approval for psoriasis vulgaris treatment

Kyowa Hakko Kirin Co., Ltd., a provider of medical products, has announced that LEO Pharma K.K., a research-based company, has received Japanese manufacturing and marketing approval for Dovobet Ointment to treat psoriasis vulgaris. LEO Pharma K.K. filed ... [Published Individual.com - Jul 14 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Dovobet ointment approved to treat psoriasis vulgaris

Kyowa Hakko Kirin Co., Ltd. (headquarters: Chiyoda-ku, Tokyo; President and CEO: Nobuo Hanai; "Kyowa Hakko Kirin") announced today that LEO Pharma K.K. (headquarters: Chiyoda-ku, Tokyo; General Manager and Japan Representative Director: Stefan Sakurai; ... [Published PBR - News - Jul 07 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

03-07-2014 New interim head of GPS

Anders B. Spohr, Executive Vice President for Global Product Supply, has taken up a position with Novo-owned Xellia Pharmaceuticals."As leader of LEO Pharma's Global Product Supply, Anders has proven pivotal in our continued work to secure the flexible, ... [Published Noodls - Jul 03 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

02-07-2014 Awards for pioneering scientists in skin research

The DKK 1 million Gold Award goes to Ph.D. Kim B. Jensen, associate professor at the Biotech Re and Innovation Centre at the University of Copenhagen. The DKK 500,000 Silver Award goes to Dr. med. Christina Zielinski, re group leader and dermatological ... [Published Noodls - Jul 02 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

Foamix Pharmaceuticals establishes new US subsidiary

Foamix Pharmaceuticals, a specialty pharmaceutical company, has established a new US subsidiary and appointed new management team. Dave Domzalski has been appointed President of Foamix Pharmaceuticals Inc., the US subsidiary of Foamix Ltd., Dr Herman ... [Published Individual.com - Jun 30 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 3 reports

Antares Pharma Receives Second Milestone Payment from LEO Pharma in OTREXUP Collaboration

EWING, N.J.--(EON: Enhanced Online News)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the receipt of a second milestone payment of $5 million from LEO Pharma. The milestone payment was received in connection with the launch of OTREXUP and the ... [Published EON Science - Mar 12 2014]

Quotes

...help," lead author Marc A Rodger, MD, professor of the Faculty of Medicine at the University of Ottawa, Ontario, Canada, said in a news release. "However, I'm very glad that we can now spare these women all those unnecessary needles."
"Specific expertise in life sciences is extremely attractive to firms with active corporate practices in Silicon Valley" Watanabe said. "I expect this trend to continue."
"These results mean that many women around the world can save themselves a lot of unnecessary pain during pregnancy" Dr. Rodger said in a press statement. "Using [LMWH] unnecessarily medicalizes a woman's pregnancy and is costly...
"We hope these results will facilitate the development of clinical trials to explore therapies in defined sets of patients, ultimately improving survival of this deadly disease" write the researchers

More Content

All (39) | News (29) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Thrombophilia of Pregnancy: Heparin Doesn’t Imp... [Published Diabetes Care - Jul 25 2014]
DLA Takes Life Science Partner From Hogan's Val... [Published Recorder - Jul 25 2014]
Common Treatment for Pregnant Women May Be Inef... [Published Daily Rx - Jul 25 2014]
LMWH did not reduce complications in pregnant w... [Published Orthopedics Today - Jul 25 2014]
New Classification of Gastric Cancer Spurs Targ... [Published Diabetes Care - Jul 24 2014]
Pre-Filled Syringes Market (2nd Edition), 2014 ... [Published RCL Advisors - Jul 21 2014]
Virobay banks $8M to accelerate its treatments ... [Published FierceBiotech - Jul 17 2014]
Laser discovery treats skin cancer without leav... [Published Copenhagen Post - Jul 17 2014]
LEO Pharma, KLOX Tech to develop BioPhotonic ac... [Published Orthopedics Today - Jul 16 2014]
LEO Pharma strikes global dermatology deal with... [Published Pharma Letter - Jul 16 2014]
Leo Pharma and Klox Technologies agree dermatol... [Published Zenopa - Jul 16 2014]
New Market Research Report: LEO Pharma A/S - Pr... [Published Fat Pitch Financials - Jul 15 2014]
LEO Pharma & KLOX Technologies strike global de... [Published BusinessWeek - Jul 15 2014]
LEO Pharma & KLOX Technologies strike global de... [Published PR Newswire: Financial Services - Jul 15 2014]
LEO Pharma & KLOX Technologies strike global de... [Published Financial Services - Jul 15 2014]
LEO Pharma receives marketing approval for psor... [Published Individual.com - Jul 14 2014]
Dovobet ointment approved to treat psoriasis vu... [Published PBR - News - Jul 07 2014]
03-07-2014 New interim head of GPS [Published Noodls - Jul 03 2014]
Herald Express published Psoriasis website laun... [Published Torquay Herald Express - Jul 02 2014]
Langland achieves big wins at IPA Best of Healt... [Published Zenopa - Jul 02 2014]
02-07-2014 Awards for pioneering scientists in ... [Published Noodls - Jul 02 2014]
Foamix Pharmaceuticals establishes new US subsi... [Published Individual.com - Jun 30 2014]
Psoriasis sufferer 'let down by GP' [Published BBC - Jun 28 2014]
IPA Best of Health Award winners revealed [Published Pharma Times - Jun 27 2014]
Antares Pharma Appoints Eamonn Hobbs CEO [Published Citybizlist - Jun 24 2014]
Antares Pharma Announces Changes in Senior Lead... [Published Nasdaq - Jun 24 2014]
Antares Pharma Reports First Quarter 2014 Opera... [Published Business Wire Health News - May 09 2014]
Stop Paying Lip Service to Patient-Centricity [Published Pharmaceutical Executive - Apr 10 2014]
Perrigo launches generic Taclonex ointment to t... [Published PharmaBiz - Apr 03 2014]
Perrigo launches generic version of Taclonex oi... [Published PBR - News - Apr 02 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
LEO Pharma & KLOX Technologies strike global de... [Published PR Newswire: Financial Services - Jul 15 2014]
Dermatology leader LEO Pharma expands into acne, further pushing the boundaries of dermatology careKLOX gains access to global market, cementing its position as a leading Canadian life sciences specialty companyBALLERUP, Denmark and LAVAL, QC, July 15, ...
Dovobet ointment approved to treat psoriasis vu... [Published PBR - News - Jul 07 2014]
Kyowa Hakko Kirin Co., Ltd. (headquarters: Chiyoda-ku, Tokyo; President and CEO: Nobuo Hanai; "Kyowa Hakko Kirin") announced today that LEO Pharma K.K. (headquarters: Chiyoda-ku, Tokyo; General Manager and Japan Representative Director: Stefan Sakurai; ...
Antares Pharma Reports First Quarter 2014 Opera... [Published Business Wire Health News - May 09 2014]
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the first quarter ended March 31, 2014. Quarter and Recent Highlights Announced the product launch of OTREXUP™ (methotrexate) injection ...
Perrigo launches generic version of Taclonex oi... [Published PBR - News - Apr 02 2014]
Ireland-based Perrigo Company has started market launch and made its first shipments of the authorized generic version of LEO Pharma's Taclonex Ointment (calcipotriene 0.005% / betamethasone dipropionate 0.064%). ...
PICATO (Ingenol Mebutate) Gel [LEO Pharma Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Mar 24 2014]
Updated Date: Mar 24, 2014 EST ...
1 2

Press Releases

sort by: Date | Relevance
LEO Pharma & KLOX Technologies strike global de... [Published Financial Services - Jul 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.